B. O. Depelchin

874 total citations · 1 hit paper
7 papers, 714 citations indexed

About

B. O. Depelchin is a scholar working on Surgery, Small Animals and Molecular Biology. According to data from OpenAlex, B. O. Depelchin has authored 7 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Surgery, 1 paper in Small Animals and 1 paper in Molecular Biology. Recurrent topics in B. O. Depelchin's work include Nanoparticle-Based Drug Delivery (1 paper), Virus-based gene therapy research (1 paper) and Cancer Research and Treatments (1 paper). B. O. Depelchin is often cited by papers focused on Nanoparticle-Based Drug Delivery (1 paper), Virus-based gene therapy research (1 paper) and Cancer Research and Treatments (1 paper). B. O. Depelchin collaborates with scholars based in Belgium, United States and Switzerland. B. O. Depelchin's co-authors include Karen Tilmant, Helga H.J. Gerets, Stéphane Dhalluin, Hugues Chanteux, Brigitte Gerin, Franck A. Atienzar, Jennifer Sims, Andreas Baumann, Laurie Tsuruda and Theodora W. Salcedo and has published in prestigious journals such as Toxicology Letters, Acta Neurologica Scandinavica and Toxicologic Pathology.

In The Last Decade

B. O. Depelchin

7 papers receiving 699 citations

Hit Papers

Characterization of primary human hepatocytes, HepG2 cell... 2012 2026 2016 2021 2012 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. O. Depelchin Belgium 6 266 176 169 144 88 7 714
Franck A. Atienzar Belgium 11 327 1.2× 243 1.4× 208 1.2× 204 1.4× 97 1.1× 12 913
Stéphane Dhalluin France 11 341 1.3× 233 1.3× 203 1.2× 195 1.4× 92 1.0× 19 919
Ruoya Li France 12 294 1.1× 242 1.4× 150 0.9× 95 0.7× 211 2.4× 16 773
Thomas K. Baker United States 16 335 1.3× 130 0.7× 78 0.5× 100 0.7× 109 1.2× 28 818
Bridgett Green United States 12 492 1.8× 199 1.1× 76 0.4× 75 0.5× 119 1.4× 13 881
Malin Darnell Sweden 11 162 0.6× 220 1.3× 191 1.1× 217 1.5× 99 1.1× 15 564
Eliane Alexandre France 18 204 0.8× 307 1.7× 391 2.3× 93 0.6× 183 2.1× 31 945
Gregor Tuschl Germany 9 300 1.1× 397 2.3× 411 2.4× 259 1.8× 290 3.3× 14 1.1k
Henk Koster Netherlands 14 158 0.6× 286 1.6× 146 0.9× 71 0.5× 174 2.0× 22 701
Tomáš Smutný Czechia 17 224 0.8× 219 1.2× 47 0.3× 50 0.3× 162 1.8× 33 710

Countries citing papers authored by B. O. Depelchin

Since Specialization
Citations

This map shows the geographic impact of B. O. Depelchin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. O. Depelchin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. O. Depelchin more than expected).

Fields of papers citing papers by B. O. Depelchin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. O. Depelchin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. O. Depelchin. The network helps show where B. O. Depelchin may publish in the future.

Co-authorship network of co-authors of B. O. Depelchin

This figure shows the co-authorship network connecting the top 25 collaborators of B. O. Depelchin. A scholar is included among the top collaborators of B. O. Depelchin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. O. Depelchin. B. O. Depelchin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Delaunois, Annie, et al.. (2015). Cardiac safety of lacosamide: the non-clinical perspective. Acta Neurologica Scandinavica. 132(5). 337–345. 10 indexed citations
2.
Ivens, Inge A., Andreas Baumann, Joy Cavagnaro, et al.. (2015). PEGylated Biopharmaceuticals. Toxicologic Pathology. 43(7). 959–983. 124 indexed citations
3.
Delaunois, Annie, et al.. (2013). Advantageous safety profile of a dual selective alpha2C agonist/alpha2A antagonist antinociceptive agent. Fundamental and Clinical Pharmacology. 28(4). 423–438. 2 indexed citations
4.
Gerets, Helga H.J., Karen Tilmant, Brigitte Gerin, et al.. (2012). Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biology and Toxicology. 28(2). 69–87. 551 indexed citations breakdown →
5.
Depelchin, B. O., et al.. (1996). Vascular lesions in a 1-month toxicity study with a serotoninergic agent in beagle dogs. Toxicology Letters. 88. 109–109. 5 indexed citations
6.
Depelchin, B. O., et al.. (1988). Effects of age, sex and breed on antipyrine disposition in calves. Research in Veterinary Science. 44(2). 135–139. 17 indexed citations
7.
Depelchin, B. O., et al.. (1987). Antipyrine disposition in calves. I. Effects of some drugs. Journal of Veterinary Pharmacology and Therapeutics. 10(1). 49–53. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026